W. Hague

发表

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

R. Collins, G. Hankey, A. Keech, 1998, The New England journal of medicine.

Oxygen saturation and outcomes in preterm infants.

M. Meyer, L. Doyle, P. Davis, 2013, The New England journal of medicine.

The effect of lactoferrin supplementation on death or major morbidity in very low birthweight infants (LIFT): a multicentre, double-blind, randomised controlled trial.

A. Keech, R. Simes, D. Isaacs, 2020, The Lancet. Child & adolescent health.

Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.

I. Reid, A. Tonkin, J. Emberson, 2001, Lancet.

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up

A. Keech, A. Tonkin, R. Simes, 2002, The Lancet.

Recruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategies

A. Keech, David Handelsman, B. Yeap, 2019, Trials.

SPAR – a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG clinical trial

F. Frizelle, S. Ackland, C. Karapetis, 2019, BMC Cancer.

Recruitment to randomised studies

V. Gebski, A. Keech, W. Hague, 2003, The Medical journal of Australia.

Recruitment strategies in randomised controlled trials of men aged 50 years and older: a systematic review

A. Keech, G. Wittert, L. Askie, 2019, BMJ Open.

A database design for automated data management of multicenter clinical trials

V. Gebski, R. Simes, A. Nguyen, 1991 .

Outcomes of Two Trials of Oxygen-Saturation Targets in Preterm Infants.

L. Doyle, P. Davis, C. Morley, 2016, The New England journal of medicine.

A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trial

V. Gebski, A. Keech, A. Jenkins, 2019, Clinical trials.

Relationship Between Lipid Levels and Clinical Outcomes in the Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Trial To What Extent Is the Reduction in Coronary Events With Pravastatin Explained by On-Study Lipid Levels? Clinical Investigation and Reports

A. Keech, I. Marschner, H. White, 2002 .

M. Stockler, W. Parulekar, M. Frydenberg, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Value of central review of RECIST v1.1 outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancer

M. Stockler, V. Gebski, D. Moses, 2022, Journal of Cancer Research and Clinical Oncology.

Performance of the Parent Report of Children's Abilities–Revised (PARCA-R) versus the Bayley Scales of Infant Development III

A. Salt, W. Tarnow-Mordi, W. Hague, 2013, Archives of Disease in Childhood.

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.

M. Stockler, W. Parulekar, M. Frydenberg, 2019, The New England journal of medicine.

Disease-free Survival and Local Recurrence After Laparoscopic-assisted Resection or Open Resection for Rectal Cancer: The Australasian Laparoscopic Cancer of the Rectum Randomized Clinical Trial

V. Gebski, J. Simes, W. Hague, 2019, Annals of surgery.

Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial.

John Simes, Val J Gebski, V. Gebski, 2015, JAMA.

Cancer Molecular Screening and Therapeutics (MoST): a framework for multiple, parallel signal‐seeking studies of targeted therapies for rare and neglected cancers

David M. Thomas, P. Butow, R. Simes, 2018, The Medical journal of Australia.

INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)

V. Gebski, N. Pavlakis, Y. Bang, 2023, BMC Cancer.

Benefits of Pravastatin on Cardiovascular Events and Mortality in Older Patients with Coronary Heart Disease Are Equal to or Exceed Those Seen in Younger Patients: Results from the LIPID Trial

A. Tonkin, D. Hunt, J. Simes, 2001, Annals of Internal Medicine.

Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy.

M. Stockler, W. Parulekar, M. Frydenberg, 2021, European urology.

Challenges of international oncology trial collaboration—a call to action

R. Simes, H. Joensuu, J. Zalcberg, 2019, British Journal of Cancer.

Relationship Between Lipid Levels and Clinical Outcomes in the Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Trial: To What Extent Is the Reduction in Coronary Events With Pravastatin Explained by On-Study Lipid Levels?

A. Keech, I. Marschner, H. White, 2002, Circulation.

Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study

A. Keech, H. White, P. Glasziou, 2016, Circulation.

Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study.

A. Keech, H. White, S. Blankenberg, 2015, International journal of cardiology.

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up

David Colquhoun, Stephen MacMahon, Andrew Tonkin, 2002, The Lancet.

D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study

A. Keech, H. White, S. Blankenberg, 2018, Circulation.

Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study

David Hunt, Stephen MacMahon, David Colquhoun, 2000, The Lancet.

Effect of pravastatin on frequency of fracture in the LIPID study: secondly analysis of a randomised controlled trial

I. Reid, A. Tonkin, J. Emberson, 2001, The Lancet.

Delayed versus Immediate Cord Clamping in Preterm Infants

V. Gebski, A. Keech, N. Marlow, 2017, The New England journal of medicine.

Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.

A. Keech, A. Tonkin, E. Beller, 2003, Diabetes care.

Identification of infants with major cognitive delay using parental report

A. Salt, W. Tarnow-Mordi, W. Hague, 2012, Developmental medicine and child neurology.

Low-dose aspirin for preventing recurrent venous thromboembolism.

D. Xavier, J. Eikelboom, J. Simes, 2012, The New England journal of medicine.

Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.

V. Gebski, A. Keech, A. Jenkins, 2021, The lancet. Diabetes & endocrinology.

Testosterone therapy to prevent type 2 diabetes mellitus in at‐risk men (T4DM): Design and implementation of a double‐blind randomized controlled trial

V. Gebski, A. Keech, A. Jenkins, 2019, Diabetes, obesity & metabolism.

Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.

A. Tonkin, D. Hunt, J. Simes, 2003, American heart journal.

Effects of delayed versus immediate umbilical cord clamping in reducing death or major disability at 2 years corrected age among very preterm infants (APTS): a multicentre, randomised clinical trial.

A. Keech, J. Simes, K. Lui, 2021, The Lancet. Child & adolescent health.

Randomised phase 3 trial of enzalutamide in androgen deprivation therapy (ADT) with radiation therapy for clinically localised high-risk or node-positive prostate cancer: ENZARAD (ANZUP 1303).

M. Stockler, S. Hughes, I. Davis, 2016 .

Patient-Reported Bowel, Urinary, and Sexual Outcomes After Laparoscopic-Assisted Resection or Open Resection for Rectal Cancer

V. Gebski, R. Simes, W. Hague, 2022, Annals of surgery.

Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial.

V. Gebski, J. Simes, W. Hague, 2015, JAMA.

Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial.

V. Gebski, J. Simes, W. Hague, 2015, JAMA.

ASO Author Reflections: Is laparoscopic-Assisted Surgery More Costly than Traditional Open Resection for Rectal Cancer Treatment?

J. Simes, W. Hague, R. Morton, 2022, Annals of Surgical Oncology.

Healthcare Costs of Laparoscopic versus Open Surgery for Rectal Cancer Patients in the First 12 Months: A Secondary Endpoint Analysis of the Australasian Laparoscopic Cancer of the Rectum Trial (ALaCaRT)

J. Simes, W. Hague, R. Morton, 2021, Annals of Surgical Oncology.

Return to work following laparoscopic‐assisted resection or open resection for rectal cancer: Findings from AlaCaRT—Australasian Laparoscopic Cancer of the Rectum Trial

J. Simes, Chris Brown, W. Hague, 2020, Cancer medicine.

Telephone call reminders did not increase screening uptake more than SMS reminders: a recruitment study within a trial.

V. Gebski, A. Keech, A. Jenkins, 2019, Journal of clinical epidemiology.

Delayed versus Immediate Cord Clamping in Preterm Infants

V. Gebski, A. Keech, N. Marlow, 2017, The New England journal of medicine.

Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial.

V. Gebski, J. Simes, W. Hague, 2015, JAMA.

Identification of infants with major cognitive delay using parental report

A. Salt, W. Tarnow-Mordi, W. Hague, 2012, Developmental medicine and child neurology.

SPAR: A randomized placebo-controlled phase 2 trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: An AGITG clinical trial.

F. Frizelle, S. Ackland, C. Karapetis, 2022, Journal of Clinical Oncology.

Randomised phase 3 trial of enzalutamide in first-line androgen deprivation therapy for metastatic prostate cancer: The ANZUP ENZAMET Trial (ANZUP 1304).

M. Stockler, I. Davis, F. Vera-Badillo, 2015 .